Key statistics dashboard for Praxis Precision Medicines, Inc. (PRAX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity.
Stock Data
| Price | $308.99 |
| Market Cap | $8.6B |
| Enterprise Value | $8.20B |
| Beta | 2.97 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -24.16 |
| Price / Book | 6.80 |
| P/S | 0.00 |
| EV/EBITDA | -24.18 |
| EV/Sales | 0.00 |
| EV/FCF | -26.79 |
| P/FCF | -28.51 |
| Earnings Yield | -3.74% |
| FCF Yield | -3.53% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -34.15% |
| Return on Assets | -24.40% |
| Return on Invested Capital | -28.18% |
| Return on Capital Employed | -28.20% |
Financial Health
| Current Ratio | 15.73 |
| Quick Ratio | 15.73 |
| Cash Ratio | 9.68 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.08% |
| Net Debt / EBITDA | 1.40 |
| Interest Coverage | 0.00 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 46.03 |
| Cash per share | 26.04 |
| FCF per share | -10.50 |
| Tangible Book Value per share | 46.03 |
| Dividend per share | 0.00 |
Related companies: ACAD · AKRO · CNTA · CRNX · IMVT · KYMR · LGND
Explore sector: Healthcare · Biotechnology
More sections of PRAX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks